Product NDC: | 43063-392 |
Proprietary Name: | Hydralazine Hydrochloride |
Non Proprietary Name: | Hydralazine Hydrochloride |
Active Ingredient(s): | 50 mg/1 & nbsp; Hydralazine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-392 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA086242 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070406 |
Package NDC: | 43063-392-90 |
Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-392-90) |
NDC Code | 43063-392-90 |
Proprietary Name | Hydralazine Hydrochloride |
Package Description | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-392-90) |
Product NDC | 43063-392 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydralazine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20070406 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | HYDRALAZINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |